These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 16598960)

  • 1. [A new patient focused scale for measuring quality of life in schizophrenic patients: the Schizophrenia Quality of Life Scale (SOL)].
    Martin P; Caci H; Azorin JM; Daléry J; Hardy-Baylé MC; Etienne D; Gérard D; Peretti CS;
    Encephale; 2005; 31(5 Pt 1):559-66. PubMed ID: 16598960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Caregiver burden in relatives of persons with schizophrenia: an overview of measure instruments].
    Reine G; Lancon C; Simeoni MC; Duplan S; Auquier P
    Encephale; 2003; 29(2):137-47. PubMed ID: 14567165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development and validation of a self rating quality of life scale: the S-QoL].
    Lançon C; Reine G; Simeoni MC; Aghababian V; Auquier P
    Encephale; 2007; 33(3 Pt 1):277-84. PubMed ID: 17675924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between insight and self-reported quality of life among shizophrenic patients].
    Aghababian V; Auquier P; Baumstarck-Barrau K; Lançon C
    Encephale; 2011 Jun; 37(3):162-71. PubMed ID: 21703431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The subjective quality of life of patients with schizophrenia: influence of psychopathology and patients' expectations. A comparative study].
    Salomé F; Petitjean F; Germain C; Demant JC
    Encephale; 2004; 30(1):60-8. PubMed ID: 15029078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personal evaluation of transitions in treatment (PETiT):a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia.
    Voruganti LN; Awad AG
    Schizophr Res; 2002 Jul; 56(1-2):37-46. PubMed ID: 12084418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A preliminary validation of a new French instrument to assess quality of life for caregivers of patients suffering from schizophrenia].
    Richieri R; Boyer L; Reine G; Loundou AD; Simeoni MC; Auquier P; Lançon C
    Encephale; 2011 Dec; 37(6):425-32. PubMed ID: 22137214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evolution of the social autonomy scale (EAS) in schizophrenic patients depending on their management].
    Leguay D; Rouillon F; Azorin JM; Gasquet I; Loze JY; Arnaud R; Dillenschneider A
    Encephale; 2010 Oct; 36(5):397-407. PubMed ID: 21035630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor structure in the Camberwell Assessment of Need-Patient Version: the correlations with dimensions of illness, personality and quality of life of schizophrenia patients.
    Ritsner MS; Lisker A; Arbitman M; Grinshpoon A
    Psychiatry Clin Neurosci; 2012 Oct; 66(6):499-507. PubMed ID: 23066767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Validation of the French version of the self-evaluation of negative symptoms (SNS)].
    Hervochon C; Bourgeois V; Rotharmel M; Duboc JB; Le Goff B; Quesada P; Campion D; Dollfus S; Guillin O
    Encephale; 2018 Dec; 44(6):512-516. PubMed ID: 29195803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schizophrenia Quality of Life Scale: validation of the Japanese version.
    Kaneda Y; Imakura A; Fujii A; Ohmori T
    Psychiatry Res; 2002 Dec; 113(1-2):107-13. PubMed ID: 12467950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects and side effects of antipsychotic treatment in schizophrenia: pros and cons of available self-rating scales.
    Wolters HA; Knegtering H; van den Bosch RJ; Wiersma D
    Schizophr Res; 2009 Jul; 112(1-3):114-8. PubMed ID: 19395241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
    Wehmeier PM; Kluge M; Schneider E; Schacht A; Wagner T; Schreiber W
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):703-12. PubMed ID: 17289237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a patient-based health-related quality of life questionnaire in schizophrenia: the S-QoL.
    Auquier P; Simeoni MC; Sapin C; Reine G; Aghababian V; Cramer J; Lançon C
    Schizophr Res; 2003 Sep; 63(1-2):137-49. PubMed ID: 12892868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and psychometric properties of a new brief scale for subjective personal agency (SPA-5) in people with schizophrenia.
    Yamaguchi S; Shiozawa T; Matsunaga A; Bernick P; Sawada U; Taneda A; Osumi T; Fujii C
    Epidemiol Psychiatr Sci; 2020 Apr; 29():e111. PubMed ID: 32272978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric evaluation of the Medication Satisfaction Questionnaire (MSQ) to assess satisfaction with antipsychotic medication among schizophrenia patients.
    Vernon MK; Revicki DA; Awad AG; Dirani R; Panish J; Canuso CM; Grinspan A; Mannix S; Kalali AH
    Schizophr Res; 2010 May; 118(1-3):271-8. PubMed ID: 20172695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [French validation of the Verona Service Satisfaction Scale-VSSS-54F].
    Corbière M; Lesage A; Lauzon S; Ricard N; Reinharz D
    Encephale; 2003; 29(2):110-8. PubMed ID: 14567162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
    Byerly MJ; Nakonezny PA; Rush AJ
    Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates of quality of life in an Arab schizophrenia sample.
    Zahid MA; Ohaeri JU; Elshazly AS; Basiouny MA; Hamoda HM; Varghese R
    Soc Psychiatry Psychiatr Epidemiol; 2010 Sep; 45(9):875-87. PubMed ID: 19727531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.